I-Mab (NASDAQ:IMAB) does about 560.49K shares in volume on a normal day but saw 638254 shares change hands in Tuesday trading. The company now has a market cap of 309.34M USD. Its current market price is $3.66, marking a decrease of -1.61% compared to the previous close of $3.72. The 52 week high reached by this stock is $69.90 whilst the lowest price level in 52 weeks is $3.25. The script in recent trading has seen the stock touch a high of $3.72 and a low of $3.57.
I-Mab (IMAB) has a 20-day trading average at $3.97 and the current price is -94.76% off the 52-week high compared with 12.62% distance from its 52-week low. The 50-day simple moving average of the closing price is $4.10 and its 200-day simple moving average is $10.82. If we look at the stock’s price movements over the week, volatility stands at 8.04%, which decreases to 7.82% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 42.51 to suggest the stock is neutral.
12 analysts observing the I-Mab (IMAB) stock have set the 12-month price targets for the company’s shares at between $3.80 and $64.60. The consensus objective for the share price is $40.02, suggesting that the stock has a potential upside of 90.85% over the period. The median price target is 88.8% away from the current levels at $32.67.
FactSet Research has provided data showing that 12 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 11 analysts have rated it as a buy and 1 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on December 09, 2021 when Siebert Williams Shank initiated the stock to “Buy” and issued a price target of $96. Needham initiated its price target at $75.
The current price level is -7.83%, -11.46%, and -66.47% away from its SMA20, SMA50, and SMA200 respectively, with the IMAB price moving above the 50-day SMA on November 22. I-Mab (IMAB) stock is down -24.69% over the week and 3.83% over the past month. Its price is -92.28% year-to-date and -94.44% over the past year.
The company’s next earnings report is expected on 03/28/2023.
Its 12-month price target is $32.67. To reach the target analysts have set, the stock logically needs to grow 90.85 percent from here. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $3.80, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $64.60.
Outstanding shares total 82.11M with insiders holding 1.30% of the shares and institutional holders owning 50.88% of the company’s common stock. The company has a return on investment of -45.40% and return on equity of -46.80%. Price to book ratio is 0.54 and price to sales ratio is 18.09.
According to a U.S. Securities and Exchange Commission filing, Government Pension Fund – Global has added its position in I-Mab (IMAB) to 1,069,544 shares, mirroring a recent increase by 3,465.27%. Government Pension Fund – Global added 1.04 million shares of I-Mab common stock bringing its total worth to about $3.97 million at the end of recent close, SEC documents show. Government Pension Fund – Global isn’t the only investment manager who changed stakes and is followed by Artisan International Small-Mid F, which added 0.17 million shares to end up with 793,859 shares worth $2.95 million.